ADMA Biologics ADMA Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent at other companies
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance.
The official record: ADMA Biologics’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →
Ask your AI about ADMA Biologics's effective income tax rate reconciliation, change in deferred tax assets valuation allowance, percent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ADMA Biologics's effective income tax rate reconciliation, change in deferred tax assets valuation allowance, percent?
- ADMA Biologics (ADMA) reported effective income tax rate reconciliation, change in deferred tax assets valuation allowance, percent of 0% in Q4 2025.
- What does effective income tax rate reconciliation, change in deferred tax assets valuation allowance, percent mean?
- The impact on the effective tax rate caused by adjustments to the valuation allowance for deferred tax assets. This metric reflects the volatility in tax planning and the company's outlook on its ability to utilize tax carryforwards.